Momeallerg (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momeallerg, is a corticosteroid presented as a nasal spray for nasal use. It reduces inflammation in the nasal passages of patients with allergic rhinitis and nasal polyps, providing local anti‑inflammatory action with minimal systemic absorption. The formulation is designed for topical application inside the nose, delivering a high‑potency glucocorticoid directly to the affected mucosa.

GNH USA supplies Momeallerg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows Good Distribution Practice to maintain product integrity during storage and transport, and offers regulatory documentation and technical assistance to its customers.

Momeallerg (mometasone furoate) is a topical corticosteroid that acts on the nasal mucosa to control inflammatory conditions.

Allergic rhinitis (seasonal or perennial): reduces nasal congestion, itching, sneezing and rhinorrhea. Nasal polyps: decreases polyp size and improves nasal airflow, relieving obstruction. Nasal inflammation due to irritants: provides symptomatic relief of swelling and irritation in the nasal passages.

Nasal administration of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Epistaxis (nosebleeds). - Headache. - Sore throat. - Cough.

Serious or Rare Side Effects: - Nasal septal perforation. - Adrenal suppression with prolonged high‑dose use. - Glaucoma or cataract formation. - Severe allergic reaction (anaphylaxis). - Opportunistic fungal infection of the nasal passages.

Before using Momeallerg, consider the following precautions.

Pregnancy: consult a healthcare professional before use. Children: use only as prescribed; safety not established for very young patients. Concurrent ocular surgery: postpone surgery due to risk of delayed wound healing. Active nasal infection: avoid use until infection resolved. Systemic corticosteroid therapy: monitor for additive systemic effects. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Momeallerg may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic glucocorticoid exposure. - Concurrent systemic corticosteroids: risk of additive systemic glucocorticoid effects.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance local antihistaminic effect, monitor symptom control. - Ritonavir: moderate increase in systemic exposure; observe for signs of glucocorticoid excess. - Nasal decongestant sprays: combined use may increase nasal irritation; advise spacing of applications.